Genovis AB (publ.) (STO:GENO)
Sweden
· Delayed Price · Currency is SEK 16.60
-0.08 (-0.48%)
At close: Mar 9, 2026
Genovis AB (publ.) Market Cap
Genovis AB (publ.) has a market cap or net worth of 1.10 billion as of March 9, 2026. Its market cap has decreased by -42.34% in one year.
Market Cap
1.10B
Enterprise Value
1.01B
Revenue
129.65M
Ranking
n/a
PE Ratio
46.47
Stock Price
16.60
Market Cap Chart
Since April 18, 2008, Genovis AB (publ.)'s market cap has increased from 7.51M to 1.10B, an increase of 14,495.57%. That is a compound annual growth rate of 32.12%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cantargia AB | 1.02B |
| Xspray Pharma AB | 1.01B |
| SynAct Pharma AB | 999.07M |
| Medivir AB | 837.10M |
| BioInvent International AB | 1.49B |
| Infant Bacterial Therapeutics AB | 674.92M |
| Saniona AB | 2.01B |
| Diamyd Medical AB | 2.04B |